Direktorat Registrasi ObatValid

EMLA

BPOM Number: DKI1909500229A1
Approved: 21 November 2024
Expiry: 28 February 2024
Form: KRIM; 25 MG /25 MG

About This Registration

EMLA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1909500229A1. Its current registration status is Valid, with the licence valid until 28 February 2024. The product is registered to MITSUBISHI TANABE PHARMA INDONESIA - INDONESIA. BPOM first approved this registration in April 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 1 TUBE @ 5 G
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MITSUBISHI TANABE PHARMA INDONESIA - INDONESIA
KOTA BANDUNG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

MITSUBISHI TANABE PHARMA INDONESIA - INDONESIA
KOTA BANDUNG
primary
View profile →

Ingredients (1)

LIDOCAINE. PRILOCAINE

Market Intelligence

Owner Portfolio: MITSUBISHI TANABE PHARMA INDONESIA - INDONESIA holds 52 BPOM registrations
Manufacturer Scale: MITSUBISHI TANABE PHARMA INDONESIA - INDONESIA produces 52 registered products
Registration Age: Registered for 4 years, 5 months
Expiry Status: Expired 941 days ago